Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, Lisa Takagi, and Anju Ghangurde

Plus deals involving Incyte/CMS, Biocytogen/ABL, Bharat/Biofabri/Bilthoven, Dr. Reddy’s/Pharmazz, Veeda/Heads, Sosei Heptares/GSK, BioGeometry/Sanyou, Ono/Sibylla and Teijin/BioProjet

Asia Deal Watch
• Source: Alamy

More from Deal Watch

More from Deals